| Product Type | Impurity Standards |
| CAT. No. | MRL-E55004 |
| CAS. No. | 32384-65-9 |
| Mol. Formula | C18H42O6Si4 |
| Mol. Weight | 466.86 |
| Synonyms | NA |
| Chemical Name | (3R,4S,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In Stock |
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone with CAS No:32384-65-9 is an impurity standard of Empagliflozin. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is employed for the management of type 2 diabetes mellitus. By inhibiting SGLT2 in the kidneys, empagliflozin enhances the excretion of glucose in urine, leading to a reduction in blood glucose levels. Beyond its glucose-lowering effects, clinical studies have indicated cardiovascular benefits, demonstrating a reduction in cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease. As part of a comprehensive diabetes management plan, empagliflozin is prescribed under the guidance of healthcare professionals, often complementing lifestyle modifications and other medications to optimize overall diabetes care. Buy high quality 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone from from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone